Tingley Whittemore
Tingley Whittemore, CMO, reported an open-market or private sale at Tenaya Therapeutics, Inc. involving 1871.000000 shares for an estimated $1328.04. Reported holdings after the transaction were 216352.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Aug 17, 2026
- Filing date
- Aug 18, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 218,223 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
TNYA price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0001193125-26-354517 Common Stock
- Transaction date
- Aug 17, 2026 Filed Aug 18, 2026, 12:49 AM · 1d delay
- Shares
- 1,871 sh $0.71 per share
- Estimated value
- -$1.32k Computed from shares × price
- Holdings after
- 216,352 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
+10 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Medical Officer
- F1
Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
- F2
Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $.6820 to $.7253. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., an…
- F3
Includes 108,544 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 6,000 shares of common stock acquired pursuant…
- F4
Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024.
- F5
Includes 104,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F6
Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on January 24, 2025.
- F7
Includes 99,169 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
- F8
Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 3, 2026.
- F9
Includes 93,076 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.
0 other transactions
0 recent txs